What, Why & How

On this episode of IPA’s What, Why & How podcast, Kate Gainer welcomes pharmacy colleagues from Idaho and Alaska to share what standard of care means in their respective states and how this regulatory framework allows pharmacists to better care for their patients. To Learn More: Standard of Care Resources | Standard of Care Symposium (February 22, 2025) Jennifer Adams, PharmD, EdD, a graduate of Boise State University, Idaho State University and The George Washington University, is currently employed as Associate Dean for Academic Affairs at Idaho State University. Her previous experience includes working in hospital and community pharmacy settings, as well as at the American Pharmacists Association (APhA), helping student pharmacists develop as professionals and leaders in the profession. Dr. Adams also served for nearly 10 years as the Senior Student Affairs Advisor at the American Association of Colleges of Pharmacy (AACP), providing leadership and oversight for national student affairs activities and recruitment. Nicki Chopski earned her PharmD from Idaho State University College of Pharmacy in 1997. In 2007, as a hospital pharmacist, Nicki was appointed to the Idaho Board of Pharmacy, serving for 12 years before becoming its Executive Director in 2019. In her current role as Bureau Chief of Health Professions for the Idaho Division of Occupational and Professional Licenses, she serves as the Executive Officer for the Boards of Medicine, Nursing and Pharmacy. Brandy Seignemartin, PharmD, Executive Director of the Alaska Pharmacy Association and Clinical Assistant Professor at the UAA ISU Doctor of Pharmacy Program, has a longstanding commitment to advancing the pharmacy profession. A graduate of The Washington State University College of Pharmacy and Pharmaceutical Sciences, Dr. Seignemartin’s passion for advocacy took root during her time as a student pharmacist, where she successfully led the passage of legislation in the Washington State legislature allowing interprofessional precepting between nursing, pharmacy, and medicine. In her academic role, Dr. Seignemartin is dedicated to mentoring the next generation of pharmacists, receiving the Most Influential Faculty Award in 2024. Ashley Schaber, PharmD, MBA, BCPS, is currently the Chair of the Alaska Board of Pharmacy. She graduated pharmacy school from the University of Georgia in 2006, completed a pharmacy practice residency, and has worked in health system pharmacy since 2007. She is board certified in Pharmacotherapy and holds her Master’s of Business Administration with a focus on healthcare.

On this episode of IPA’s What, Why & How podcast, Kate Gainer welcomes Anne Schlepphorst, Executive Director of the Iowa Board of Pharmacy, to discuss her many roles within the Department of Inspections, Appeals, & Licensing (DIAL), as well as the timeline for the new Board of Pharmacy rules pursuant to Governor Reynolds’ Executive Order #10 and HF 555. Anne Schlepphorst serves as the Executive Director of the Iowa Board of Pharmacy, Interim Executive Director of the Iowa Board of Nursing, and Monitoring Bureau Chief. In addition to serving the Boards of Pharmacy and Nursing, Anne truly enjoys spending time working with staff to provide some of the best professional health programming in the country for health professionals struggling with mental health, substance abuse, and/or health-related impairments. Anne has worked with the boards for the past six years and was most recently the Chief Investigator for the Iowa Boards of Pharmacy and Medicine. When not working, Anne and her husband spend most of their time at the baseball field, hockey rink, wrestling mat, or football field watching their 10- and 14-year-old boys. Resources from today’s episode: Published August 7: Iowa Administrative Bulletin: Regulatory Analysis – 481 Iowa Administrative Code Chapters 550-557 (new Iowa Board of Pharmacy rules, proposed) IPA’s Iowa Pharmacy Law & Information Resource Center (LIRC) Connect with us on LinkedIn: Kate Gainer Anne Schlepphorst Iowa Pharmacy Association

On this episode of IPA’s What, Why & How podcast, Seth Brown welcomes Andria Seip, J.D., M.S., Senior Health Policy Specialist with the Iowa Insurance Division (IID), to discuss the data collected through PBM complaints by Iowa pharmacists and IID’s focus going forward. Connect with us on LinkedIn: Seth Brown Iowa Pharmacy Association Watch for the next episode of the What, Why & How podcast on the third Friday of the month. Subscribe today so you don’t miss an episode!

For the final episode of 2023, IPA’s Seth Brown welcomes Michael Baxter, Vice President of Federal Government Affairs at the American Pharmacists Association (APhA), to discuss direct and indirect remuneration (DIR) fees and the Medicare Part D Final Rule going into effect January 1, 2024.

Following the May 2 Iowa Board of Pharmacy meeting, IPA’s Seth Brown welcomes Sue Mears from the Board of Pharmacy to discuss Executive Agency rulemaking and Executive Order #10.

Following the January 10 Iowa Board of Pharmacy meeting, IPA staff and Sue Mears from the Board of Pharmacy discuss IPA’s 2023 Legislative Priorities, the Board’s rulemaking related to the Iowa Prescription Monitoring Program (PMP), and more.

Following the October 25 Iowa Board of Pharmacy meeting, IPA staff and Andrew Funk from the Board of Pharmacy discuss the role of the Board and programs offered, updated USP compounding standards, and delegation of technical functions to nurses.